Enterprise Value
-39.32M
Cash
176.6M
Avg Qtr Burn
-1.556M
Short % of Float
0.91%
Insider Ownership
11.49%
Institutional Own.
13.15%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ORMD-0801 (ORA-D-013-1) Details Diabetes, Type 2 diabetes | Phase 3 Update | |
ORMD-0801 Details Non-alcoholic steatohepatitis , Liver disease | Phase 2 Update |